Advertisement

Topics

Pharmaceutical company receives NIH grant to treat rare endocrine disorders

14:00 EDT 10 Sep 2017 | Healio

Crinetics Pharmaceuticals, a company that focuses on therapeutics for endocrine disorders and related cancers, has received two new grants from the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH, according to a company press release. The company reports it will use the grants to develop its nonpeptide, oral somatostatin agonists for congenital hyperinsulinemia in addition to novel small-molecule drugs for Cushing’s disease.

Original Article: Pharmaceutical company receives NIH grant to treat rare endocrine disorders

NEXT ARTICLE

More From BioPortfolio on "Pharmaceutical company receives NIH grant to treat rare endocrine disorders"

Quick Search
Advertisement
 

Relevant Topic

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...